Concepedia

Anne F. de Groot

AF

Statistics

Publications

3

Citations

104

H-Index

3

Active since

2013

Affiliations

Leiden University Medical Center(Current)

Anne F. de Groot is an author at Leiden University Medical Center specializing in tumor immunology, life sciences, and immuno-oncology biomarkers.

ORCID

Publications per year

2013–2019

3

Publications

3

The blood mMDSC to DC ratio is a sensitive and easy to assess independent predictive factor for epithelial ovarian cancer survival

Saskia J. Santegoets, Anne F. de Groot, E. M. Dijkgraaf et al. · OncoImmunology · 2018 · 42 citations · Full text

, , +17

New Role of Signal Peptide Peptidase To Liberate C-Terminal Peptides for MHC Class I Presentation

Cláudia C. Oliveira, Bianca Querido, Marjolein Sluijter et al. · The Journal of Immunology · 2013 · 40 citations

, , +16

Strong CD8+ lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapy

Anne F. de Groot, Erik J. Blok, Ayoub Charehbili et al. · Breast Cancer Research and Treatment · 2019 · 22 citations · Full text

, , +17

1–3 of 3